A61P 33/10
Anthelmintics
A61P33/10 (Anthelmintics) appears on 1,321 US grants and 1,591 published applications in this corpus.
Search patents in A61P- Granted patents
- 1,321
- Published applications
- 1,591
- Assignees
- 646
- Inventors
- 3,332
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 5 | 0 |
| 1978 | 8 | 0 |
| 1979 | 11 | 0 |
| 1980 | 5 | 0 |
| 1981 | 12 | 0 |
| 1982 | 20 | 0 |
| 1983 | 10 | 0 |
| 1984 | 7 | 0 |
| 1985 | 6 | 0 |
| 1986 | 3 | 0 |
| 1987 | 9 | 0 |
| 1988 | 11 | 0 |
| 1989 | 24 | 0 |
| 1990 | 25 | 0 |
| 1991 | 24 | 0 |
| 1992 | 15 | 0 |
| 1993 | 9 | 0 |
| 1994 | 5 | 0 |
| 1995 | 17 | 0 |
| 1996 | 19 | 0 |
| 1997 | 26 | 0 |
| 1998 | 23 | 0 |
| 1999 | 22 | 0 |
| 2000 | 21 | 0 |
| 2001 | 28 | 10 |
| 2002 | 18 | 32 |
| 2003 | 23 | 57 |
| 2004 | 11 | 74 |
| 2005 | 18 | 66 |
| 2006 | 27 | 52 |
| 2007 | 22 | 48 |
| 2008 | 20 | 74 |
| 2009 | 43 | 59 |
| 2010 | 56 | 158 |
| 2011 | 40 | 107 |
| 2012 | 59 | 86 |
| 2013 | 65 | 64 |
| 2014 | 58 | 72 |
| 2015 | 62 | 90 |
| 2016 | 66 | 88 |
| 2017 | 72 | 83 |
| 2018 | 61 | 57 |
| 2019 | 47 | 56 |
| 2020 | 46 | 64 |
| 2021 | 31 | 46 |
| 2022 | 29 | 43 |
| 2023 | 19 | 29 |
| 2024 | 25 | 33 |
| 2025 | 25 | 31 |
| 2026 | 8 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Anthelmintic compounds comprising a thienopyridine structure11 Aug 2026US 12,703,706 B2Intervet Inc.
- Anthelmintic compounds comprising a pyridine structure28 Jul 2026US 12,692,233 B2Intervet Inc.
- Compositions and methods for preventing and/or treating filarial disease9 Jun 2026US 12,648,929 B2The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
- Treatment of infections of toxoplasma gondii and closely related parasites14 Apr 2026US 12,600,727 B2President and Fellows of Harvard College
- Anthelmintic compositions and methods17 Mar 2026US 12,576,129 B2University of Massachusetts
- Anthelmintic aza-benzothiophene and aza-benzofuran compounds8 Oct 2026US 2026/0308170 A1Boehringer Ingelheim Vetmedica GmbH
- Biologically compatible, biofilm disrupting composition and methods1 Oct 2026US 2026/0294861 A1
- Long-term prevention and/or treatment of a disease by slo-1 inhibitors1 Oct 2026US 2026/0294890 A1
- Anthelmintic compositions and methods24 Sep 2026US 2026/0284141 A1University of Massachusetts
- Topical pharmaceutical composition comprising an association of an isoxazoline with a macrocyclic lactone and a pyrazino-isoquinoline derivative for treating parasitic infestations in small animals3 Sep 2026US 2026/0256735 A1Agrovet Market S.A.
Most cited
By later US patents
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Human monoclonal antibodies to programmed death ligand 1 (PD-L1)628US 7,943,743 B2Medarex, Inc. · 2011
- Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions616US 6,569,463 B2Lipocine Inc. · 2003
- 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents381US 4,133,814 AEli Lilly and Company · 1979